Medicare Patients Wait Average of 34 Days to See Neurologist After Referral
WEDNESDAY, Jan. 8, 2025 -- After being referred by their physician, Medicare patients wait an average of 34 days to see a neurologist, according to study published online Jan. 8 in Neurology.
Chun Chieh Lin, Ph.D., from The Ohio State University in Columbus, and colleagues conducted a cross-sectional study using a 2018 to 2019 Medicare sample of patients with a new visit to a neurologist. The primary outcome was wait time between the last visit with a referring physician and the first visit with a neurologist. A total of 163,313 Medicare beneficiaries who had a new patient visit with a neurologist in 2018 to 2019 after being referred by their physician were identified.
The researchers found that the median wait time to the index neurologist visit was 34 days; 18 percent of patients waited more than 90 days. Compared with patients with back pain, those with multiple sclerosis (MS), epilepsy, and Parkinson disease (PD) had to wait an average of 29.4, 10.4, and 9.3 days longer, respectively. No significant differences were seen in wait times across race/ethnicity and sex. No significant differences were seen in wait times across regions with varying levels of neurologist availability. The wait time was extended by an average of 11 days when patients visited a neurologist located outside of their residential or referring physician's hospital referral region.
"Patients with MS, epilepsy, and PD had to wait longer to see neurologists despite requiring complicated care best provided by neurologists," the authors write. "We need innovative approaches to improve timely access to neurologists."
Several authors disclosed ties to the medical device industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Features of Immunesenescence Present in Early Stages of Rheumatoid Arthritis
THURSDAY, Sept. 11, 2025 -- Some features of immunesenescence are present in the very early stages of rheumatoid arthritis (RA), according to a study published online Sept. 3 in...
Urine Biomarker Panel Sensitive, Specific for Prostate Cancer Diagnosis
THURSDAY, Sept. 11, 2025 -- A urine-based biomarker panel has high accuracy for diagnosing prostate cancer (PCa), according to a study published in the September issue of...
Hospitals Vary in Their Definition of Blood Culture Contamination
THURSDAY, Sept. 11, 2025 -- U.S. hospitals vary in how they define blood culture contamination (BCC), according to a study published online July 11 in the Journal of Clinical...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.